查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362948

基因合成（用于研究）市场规模、份额、趋势分析报告：按方法、按研究阶段、按用途、按服务、按最终用途、细分趋势，2023-2030

Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

基因合成（研究）市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球基因合成（研究）市场规模预计将达到51.4亿美元，2023年至2030年年复合成长率为16.1%。

促进市场成长的主要要素是研发活动的增加、市场竞争的加剧、合成生物学领域研发的增加。与基因合成相关的广泛用途预计也将推动市场成长。基因合成所涉及的方法具有独特的优点，可以广泛应用。例如，基因合成中涉及的固相合成技术可以透过使用过量的溶液相试剂来加速合成反应。

无需在每个步骤后进行精製步骤即可进行。此外，该方法可以帮助简化合成过程。因此，包括安捷伦科技和 Blue Heron Biotech 在内的多家公司正在使用固相合成进行基因合成。过去几年，人们对合成生物学和基因合成研发活动的兴趣日益浓厚，大大推动了市场成长。此外，进行合成生物学和基因合成相关研究活动的研究机构和大学的建立预计将支持市场成长。例如，哥本哈根大学合成生物学中心是丹麦进行合成生物学研究的主要部门之一。

此外，基因合成市场的领先公司 Integrated DNA Technologies (IDT) 将于 2023 年 2 月推出 Collab Network，以连接行业合作伙伴和研究人员，以进行有影响力的研究和技术开发。这些要素预计将在未来年度促进基因合成的成长。此外，日益激烈的行业竞争正在加强基因合成服务。主要企业正在采取各种方法来提供具有成本效益的服务并巩固其在行业中的地位。这些市场参与者专注于市场即将出现的机会。例如，基因合成公司 Evonetix 的团队参加了在洛杉矶举行的合成生物学：合成生物学：工程、进化和设计 (SEED) 2023 会议，以推动合成生物学的进步。我理解。

基因合成（研究）市场报告亮点：

  • 由于固相合成方法提供的各种优势和好处以及许多参与者的广泛采用，固相合成细分市场将在 2022 年见证最高的收益占有率。
  • 由于基因合成的高采用率及其在抗体开发中的有效性，抗体 DNA 合成服务领域在 2022 年占据了最大的收益占有率。
  • 基因与细胞治疗开发应用领域预计将在 2022 年占据最大的收益占有率，并在预测期内实现最快的年复合成长率。基因和细胞疗法开发活动的增加正在推动细分市场的成长。
  • 临床研究阶段细分市场在 2022 年占据最大的收益占有率，预计在预测期内复合年复合成长率最快。政府的支持政策和基因合成在基因治疗开发中的重要作用预计将推动该领域的成长。
  • 2022 年，学术和政府研究最终用途部分占最大份额。对合成生物学研究的兴趣和关注的增加预计将推动该领域的成长。
  • 由于该地区存在各种主要企业，北美在 2022 年占据了最大的市场占有率。由于治疗药物开发研究活动的增加，预计亚太地区在预测期内年复合成长率最快。

目录

第1章调查方法与范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系预测
  • 市场趋势及展望
  • 市场动态
  • 产业分析工具

第4章基因合成（研究用）市场：方法估计与趋势分析

  • 全球基因合成（研究）市场：方法变异分析
  • 固相合成
  • 基于晶片的合成
  • 基于PCR的酶合成

第5章基因合成（研究用）市场：服务评估与趋势分析

  • 全球基因合成（研究）市场：服务波动分析
  • 抗体DNA合成
  • 病毒DNA合成
  • 其他的

第6章基因合成（研究用）市场：用途估计与趋势分析

  • 全球基因合成（研究）市场：用途变异分析
  • 基因和细胞疗法的发展
  • 疫苗开发
  • 其他的

第7章基因合成（研究）市场：研究阶段估算与趋势分析

  • 全球基因合成（研究）市场：研究阶段波动分析
  • 临床前
  • 临床

第8章基因合成（研究）市场：最终用途估计与趋势分析

  • 全球基因合成（研究）市场：最终用途变异分析
  • 生物製药和製药公司
  • 学术和政府研究机构
  • 合约研究组织

第9章基因合成（研究用）市场：区域估计及趋势分析

  • 基因合成（研究）市场：区域展望
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第10章竞争形势

  • 公司分类
  • 策略规划
  • Company Share Analysis, 2022
  • 公司简介/名单
    • GenScript
    • Azenta, Inc.（GENEWIZ）
    • Boster Biological Technology
    • Twist Bioscience
    • ProteoGenix, Inc
    • Biomatik.
    • ProMab Biotechnologies, Inc.
    • Thermo Fisher Scientific, Inc
    • Integrated DNA Technologies, Inc.（Danaher）
    • OriGene Technologies, Inc.
Product Code: GVR-4-68040-114-3

Gene Synthesis (Research Use) Market Growth & Trends:

The global gene synthesis (research use) market size is expected to reach USD 5.14 billion by 2030 and is expected to grow at a CAGR of 16.1% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market growth is primarily propelled by the growing number of research & development activities, increasing market competition, and the rising development in the field of synthetic biology. The wide range of applications associated with gene synthesis is also projected to drive the market growth. The methods involved in gene synthesis have unique advantages and make it feasible for widespread use. For instance, the solid-phase synthesis technique involved in gene synthesis allows for the acceleration of synthesis reaction by using solution-phase reagents in excess.

It can be conducted without the need for a purification process after each step. In addition, this method helps in improving the efficiency of the synthesis process. Thus, several companies, including Agilent Technology and Blue Heron Biotech, use solid-phase synthesis methods for gene synthesis. The market growth has been fueled significantly during the last few years owing to the growing interest in synthetic biology and gene synthesis research and development activities. In addition, established research institutions and universities that conduct research activities on synthetic biology and gene synthesis are expected to support the market growth. For instance, the Center for Synthetic Biology at the University of Copenhagen is one of the leading departments conducting research on synthetic biology in Denmark.

In addition, Integrated DNA Technologies (IDT), a major company in the gene synthesis market, introduced the Collab Network in February 2023, which unites industry partners and researchers for impactful research and technological development. These factors are expected to augment the growth in gene synthesis in the coming years. Furthermore, the growing industry competition strengthens gene synthesis services. Key companies implement various approaches to provide cost-effective services and bolster their position in the industry. These market players are focusing on upcoming opportunities in the market. For instance, a team of Evonetix, a company in gene synthesis, attended the Synthetic Biology: Engineering, Evolution & Design (SEED) 2023 conference in Los Angeles to understand the advances in synthetic biology, which can help them reinforce their position in the gene synthesis and synthetic biology industry.

Gene Synthesis (Research Use) Market Report Highlights:

  • The solid-phase synthesis segment witnessed the highest revenue share in 2022 due to various benefits & advantages offered by this method and its high adoption by many players
  • The antibody DNA synthesis services segment held the largest revenue share in 2022 due to the high adoption of gene synthesis and its effectiveness in developing antibodies
  • The gene & cell therapy development application segment held the largest revenue share in 2022 and is expected to register the fastest CAGR over the forecast period. A rising number of gene & cell therapy development activities drives segment growth
  • The clinical research phase segment held the largest revenue share in 2022 and is expected to witness the fastest CAGR over the forecast period. Supportive government policies and the important role of gene synthesis in developing gene therapies are anticipated to drive the segment growth
  • The academic & government research institutions end-use segment accounted for the largest share in 2022. The growing interest and emphasis on synthetic biology research are expected to propel the segment's growth
  • North America held the largest market share in 2022 due to the presence of various prominent players in the region. Asia Pacific is anticipated to register the fastest CAGR during the forecast period owing to the rising number of research activities for the development of therapeutics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Market definitions
  • 1.2. Information Procurement
    • 1.2.1. Market formulation & data visualization
    • 1.2.2. Data validation & publishing
  • 1.3. Research Assumptions
  • 1.4. Research Methodology
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
      • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. Global Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Obective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Rising investment in synthetic biology market
      • 3.3.1.2. Advent of enzymatic DNA synthesis process
      • 3.3.1.3. Technological advancements in the DNA synthesis platforms
      • 3.3.1.4. Declining price of DNA synthesis & sequencing
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Lack of skilled professionals
      • 3.3.2.2. Misuse of gene synthesis
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Gene Synthesis (Research Use) Market: Method Estimates & Trend Analysis

  • 4.1. Global Gene Synthesis (Research Use) Market: Method Movement Analysis
  • 4.2. Solid-phase Synthesis
    • 4.2.1. Solid Phase Synthesis Market, 2018 - 2030 (USD Million)
  • 4.3. Chip-based Synthesis
    • 4.3.1. Chip Based Synthesis Market, 2018 - 2030 (USD Million)
  • 4.4. PCR-based Enzyme Synthesis
    • 4.4.1. PCR based Enzyme Synthesis Market, 2018 - 2030 (USD Million)

Chapter 5. Gene Synthesis (Research Use) Market: Service Estimates & Trend Analysis

  • 5.1. Global Gene Synthesis (Research Use) Market: Services Movement Analysis
  • 5.2. Antibody DNA Synthesis
    • 5.2.1. Antibody DNA Synthesis Market, 2018 - 2030 (USD Million)
  • 5.3. Viral DNA Synthesis
    • 5.3.1. Viral DNA Synthesis Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Gene Synthesis (Research Use) Market: Application Estimates & Trend Analysis

  • 6.1. Global Gene Synthesis (Research Use) Market: Application Movement Analysis
  • 6.2. Gene & Cell Therapy Development
    • 6.2.1. Gene & Cell Therapy Development Market, 2018 - 2030 (USD Million)
  • 6.3. Vaccine Development
    • 6.3.1. Vaccine Development Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Gene Synthesis (Research Use) Market: Research Phase Estimates & Trend Analysis

  • 7.1. Global Gene Synthesis (Research Use) Market: Research Phase Movement Analysis
  • 7.2. Preclinical
    • 7.2.1. Preclinical Market, 2018 - 2030 (USD Million)
  • 7.3. Clinical
    • 7.3.1. Clinical Market, 2018 - 2030 (USD Million)

Chapter 8. Gene Synthesis (Research Use) Market: End-use Estimates & Trend Analysis

  • 8.1. Global Gene Synthesis (Research Use) Market: End-use Movement Analysis
  • 8.2. Biopharmaceutical & Pharmaceutical Companies
    • 8.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 8.3. Academic & Government Research Institutes
    • 8.3.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.4. Contract Research Organizations
    • 8.4.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)

Chapter 9. Gene Synthesis (Research Use) Market: Region Estimates & Trend Analysis

  • 9.1. Gene Synthesis (Research Use) Market: Region Outlook
  • 9.2. North America
    • 9.2.1. North America gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. U.S. gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Canada gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.2. Germany
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Germany gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.3. France
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. France gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.4. UK
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. UK gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Italy gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Spain gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Denmark gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Sweden gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Norway gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.10. The Netherlands
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Target Disease Prevalence
      • 9.3.10.3. Competitive Scenario
      • 9.3.10.4. Regulatory Framework
      • 9.3.10.5. The Netherlands gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.11. Switzerland
      • 9.3.11.1. Key Country Dynamics
      • 9.3.11.2. Target Disease Prevalence
      • 9.3.11.3. Competitive Scenario
      • 9.3.11.4. Regulatory Framework
      • 9.3.11.5. Switzerland gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Japan gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. China gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. India gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Australia gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. South Korea gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Thailand gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America gene synthesis (research use) market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Brazil gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Mexico gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Argentina gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6. Middle East & Africa
    • 9.6.1. Middle East & Africa gene synthesis (research use) market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Saudi Arabia gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.3. South Africa
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. South Africa gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. UAE gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Kuwait gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Share Analysis, 2022
  • 10.4. Company Profiles/Listing
    • 10.4.1. GenScript
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Method Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Azenta, Inc. (GENEWIZ)
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Method Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Boster Biological Technology
      • 10.4.3.1. Overview
      • 10.4.3.2. Method Benchmarking
      • 10.4.3.3. Strategic Initiatives
    • 10.4.4. Twist Bioscience
      • 10.4.4.1. Overview
      • 10.4.4.2. Method Benchmarking
      • 10.4.4.3. Strategic Initiatives
    • 10.4.5. ProteoGenix, Inc
      • 10.4.5.1. Overview
      • 10.4.5.2. Method Benchmarking
      • 10.4.5.3. Strategic Initiatives
    • 10.4.6. Biomatik.
      • 10.4.6.1. Overview
      • 10.4.6.2. Method Benchmarking
      • 10.4.6.3. Strategic Initiatives
    • 10.4.7. ProMab Biotechnologies, Inc.
      • 10.4.7.1. Overview
      • 10.4.7.2. Method Benchmarking
      • 10.4.7.3. Strategic Initiatives
    • 10.4.8. Thermo Fisher Scientific, Inc
      • 10.4.8.1. Overview
      • 10.4.8.2. Method Benchmarking
      • 10.4.8.3. Strategic Initiatives
    • 10.4.9. Integrated DNA Technologies, Inc. (Danaher)
      • 10.4.9.1. Overview
      • 10.4.9.2. Method Benchmarking
      • 10.4.9.3. Strategic Initiatives
    • 10.4.10. OriGene Technologies, Inc.
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Method Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 4 Global gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 5 Global gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 7 Global gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 8 North America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 9 North America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 10 North America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 11 North America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 12 North America synthesis market by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 14 U.S. gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 15 U.S. gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 16 U.S. gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 17 U.S. gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 18 Canada gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 19 Canada gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 20 Canada gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 21 Canada gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 22 Canada gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 23 Europe gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 24 Europe gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 25 Europe gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 26 Europe gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 27 Europe gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 28 UK gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 29 UK gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 30 UK gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 31 UK gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 32 UK gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 33 Germany gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 34 Germany gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 35 Germany gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 36 Germany gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 37 Germany gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 38 France gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 39 France gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 40 France gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 41 France gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 42 France gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 43 Italy gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 44 Italy gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 45 Italy gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 46 Italy gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 47 Italy gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 48 Spain gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 49 Spain gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 50 Spain gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 51 Spain gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 52 Spain gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 53 Denmark gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 54 Denmark gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 55 Denmark gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 56 Denmark gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 57 Denmark gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 58 Sweden gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 59 Sweden gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 60 Sweden gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 61 Sweden gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 62 Sweden gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 63 Norway gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 64 Norway gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 65 Norway gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 66 Norway gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 67 Norway gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 68 The Netherlands gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 69 The Netherlands gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 70 The Netherlands gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 71 The Netherlands gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 72 The Netherlands gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 73 Switzerland gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
  • Table 74 Switzerland gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 75 Switzerland gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 76 Switzerland gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 77 Switzerland gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 82 Asia Pacific gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 83 Japan gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
  • Table 84 Japan gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 85 Japan gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 86 Japan gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 87 Japan gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
  • Table 88 China gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 89 China gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 90 China gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 91 China gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 92 China gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 93 India gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 94 India gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 95 India gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 96 India gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 97 India gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 98 Australia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 99 Australia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 100 Australia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 101 Australia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 102 Australia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 103 Thailand gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 104 Thailand gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 105 Thailand gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 106 Thailand gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 107 Thailand gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 108 South Korea gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 109 South Korea gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 110 South Korea gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 111 South Korea gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 112 South Korea synthesis market by Research Phase, 2018 - 2030 (USD Million)
  • Table 113 Latin America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 114 Latin America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 115 Latin America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 116 Latin America gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 117 Latin America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 118 Brazil gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 119 Brazil gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 120 Brazil gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 121 Brazil gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 122 Brazil gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 123 Mexico gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 124 Mexico gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 125 Mexico gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 126 Mexico gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 127 Mexico gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 128 Argentina gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 129 Argentina gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 130 Argentina gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 131 Argentina gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 132 Argentina gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 134 Middle East & Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 135 Middle East & Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 136 Middle East & Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 137 Middle East & Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 143 South Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 144 South Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 145 South Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 146 South Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 147 South Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 148 UAE gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 149 UAE gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 150 UAE gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 151 UAE gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 152 UAE gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 153 Kuwait gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
  • Table 154 Kuwait gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
  • Table 155 Kuwait gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
  • Table 156 Kuwait gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
  • Table 157 Kuwait gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
  • Table 158 Participant's overview
  • Table 159 Financial performance
  • Table 160 Key companies undergoing expansions
  • Table 161 Key companies undergoing acquisitions
  • Table 162 Key companies undergoing collaborations
  • Table 163 Key companies launching new products/services
  • Table 164 Key companies undergoing partnerships
  • Table 165 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Global gene synthesis (research use) market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Segment snapshot
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Market trends & outlook
  • Fig. 18 Porter's five force analysis
  • Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
  • Fig. 20 Global gene synthesis (research use) market: method outlook key takeaways
  • Fig. 21 Global gene synthesis (research use) market: method movement analysis
  • Fig. 22 Solid-phase synthesis market, 2018 - 2030 (USD Million)
  • Fig. 23 Chip-based synthesis market, 2018 - 2030 (USD Million)
  • Fig. 24 PCR-based enzyme synthesis market, 2018 - 2030 (USD Million)
  • Fig. 25 Global gene synthesis (research use) market: services outlook and key takeaways
  • Fig. 26 Global gene synthesis (research use) market: services movement analysis
  • Fig. 27 Antibody DNA synthesis market, 2018 - 2030 (USD Million)
  • Fig. 28 Viral DNA synthesis market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Global gene synthesis (research use) market: application outlook and key takeaways
  • Fig. 31 Global gene synthesis (research use) market: application movement analysis
  • Fig. 32 Gene & cell therapy development market, 2018 - 2030 (USD Million)
  • Fig. 33 Vaccine development market, 2018 - 2030 (USD Million)
  • Fig. 34 Others market, 2018 - 2030 (USD Million)
  • Fig. 35 Global gene synthesis (research use) market: End-use outlook key takeaways
  • Fig. 36 Global gene synthesis (research use) market: end-use movement analysis
  • Fig. 37 Biotechnology and pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 38 Academic and government research institutes market, 2018 - 2030 (USD Million)
  • Fig. 39 Contract research organizations market, 2018 - 2030 (USD Million)
  • Fig. 40 Global gene synthesis (research use) market: research phase outlook and key takeaways
  • Fig. 41 Global gene synthesis (research use) market: research phase movement analysis
  • Fig. 42 Preclinical market, 2018 - 2030 (USD Million)
  • Fig. 43 Clinical market, 2018 - 2030 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 US gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Target disease prevalence, 2022
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Target disease prevalence, 2022
  • Fig. 52 Key country dynamics
  • Fig. 53 Europe gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UK gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Target disease prevalence, 2022
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Target disease prevalence, 2018-2030
  • Fig. 59 Key country dynamics
  • Fig. 60 France gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Target disease prevalence 2018-2030
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Target disease prevalence 2022
  • Fig. 65 Key country dynamics
  • Fig. 66 Italy gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Target disease prevalence 2022
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Target disease prevalence
  • Fig. 71 Key country dynamics
  • Fig. 72 Sweden gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Target disease prevalence in Sweden
  • Fig. 74 Key country dynamics
  • Fig. 75 Norway gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Target disease prevalence in Norway 2022
  • Fig. 77 Key country dynamics
  • Fig. 78 Switzerland gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Target disease prevalence in Switzerland 2022
  • Fig. 80 Key country dynamics
  • Fig. 81 The Netherlands gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Target disease prevalence in The Netherlands 2022
  • Fig. 83 Key country dynamics
  • Fig. 84 Asia pacific gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Japan gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Target disease prevalence, 2022
  • Fig. 87 Key country dynamics
  • Fig. 88 China gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Target disease prevalence, 2018-2030
  • Fig. 90 Key country dynamics
  • Fig. 91 India gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Target disease prevalence 2018-2030
  • Fig. 93 Key country dynamics
  • Fig. 94 Australia gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Target disease prevalence 2022
  • Fig. 96 Key country dynamics
  • Fig. 97 Thailand gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Target disease prevalence 2022
  • Fig. 99 Key country dynamics
  • Fig. 100 South Korea gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Target disease prevalence
  • Fig. 102 Key country dynamics
  • Fig. 103 Latin America gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Brazil gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Target disease prevalence in Norway 2022
  • Fig. 106 Key country dynamics
  • Fig. 107 Mexico gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Target disease prevalence in Norway 2022
  • Fig. 109 Key country dynamics
  • Fig. 110 Argentina gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Target disease prevalence in Norway 2022
  • Fig. 112 Key country dynamics
  • Fig. 113 Middle East & Africa gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 Target disease prevalence in Norway 2022
  • Fig. 115 Key country dynamics
  • Fig. 116 South Africa gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Target disease prevalence in Norway 2022
  • Fig. 118 Key country dynamics
  • Fig. 119 Saudi Arabia gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Target disease prevalence in Norway 2022
  • Fig. 121 Key country dynamics
  • Fig. 122 UAE gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 123 Target disease prevalence in Norway 2022
  • Fig. 124 Key country dynamics
  • Fig. 125 Kuwait gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 126 Target disease prevalence in Norway 2022
  • Fig. 127 Key country dynamics
  • Fig. 128 Market participant categorization
  • Fig. 129 Company market share analysis, 2022
  • Fig. 130 Strategic framework